The National Health Commission, the National Health Insurance Administration, the State Administration of Traditional Chinese Medicine, and the National Administration for Disease Control and Prevention today issued the “Notice on Further Accomplishing the Work of Safe and Rational Use of Innovative Drugs”, which put forward specific policies and measures in terms of promoting rational preparation, strengthening training and guidance, optimizing conditions of use, and improving management measures around key aspects of the safe and rational use of innovative drugs. First, medical institutions above level 2 are required to optimize and improve the system and work process for entering hospitals for innovative drugs, hold timely meetings of the Pharmaceutical Affairs Management and Pharmacotherapeutics Committee, and promptly include innovative drugs in their medication catalogue according to their business capabilities and diagnosis and treatment needs. Promote provincial and municipal hospitals to play an exemplary and driving role step by step. Second, it is required to regularly organize and carry out training on medication knowledge and medical insurance payment policies. Prepare and publish expert consensus on the clinical use of innovative drugs in a timely manner, and promptly include drugs with sufficient evidence-based medical evidence in clinical diagnosis and treatment guidelines. The third is to implement pharmaceutical-related medical service price programs, further improve support and guarantee measures, and optimize the policy environment for the use of innovative drugs. Fourth, emphasis is placed on not limiting the total number of types of drugs in medical institutions, and making it clear that relevant innovative drugs are not included in the performance monitoring indicators of public medical institutions, such as the increase in the average cost of drugs per outpatient clinic and the increase in the average cost of drugs per hospitalization.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.